Paul Carter, PhD

Genentech Fellow, Antibody Engineering at Genentech

Speaker

Dr. Carter is a Genentech Fellow in the Antibody Engineering Department at Genentech. In 2022 he was elected to the US National Academy of Engineering “for creating novel approaches to discovering and developing life-saving antibody therapeutics, including bispecific antibodies”. Carter co-invented an antibody humanization technology used at Genentech to design 9 approved antibody therapeutics that have been administered to >10 million patients worldwide. Carter and collaborators invented knobs-into-holes and common light technologies utilized by different companies in the design of 7 approved bispecific antibodies. Carter has authored 126 scientific publications together cited >29,500 times. He is an inventor on 54 issued US patents. He has co-organized 23 international conferences on antibody engineering and antibody therapeutics. He has delivered >130 conference presentations and invited lectures including 18 keynote presentations. Carter received a B.A. in Natural Sciences from Cambridge University and his Ph.D. under Sir Greg Winter, Ph.D. at the MRC Laboratory of Molecular Biology in Cambridge. He was a Postdoctoral Fellow with Dr. Jim Wells at Genentech. Carter has 40 years of biotechnology experience including >30 years at Genentech. His professional experience includes heading the postdoctoral programs at Genentech, Immunex and Amgen. He served on the Board of Directors of the Antibody Society including as Vice President and President.